Article

  • The EMBO Journal (1999) 18, 3193 - 3203
  • doi:10.1093/emboj/18.12.3193



There is a Corrigendum (July 1999) associated with this Article.

Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state

Motohiro Horiuchi2 and Byron Caughey1

  1. Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, 903 S 4th Street, Hamilton, MT 59840, USA
  2. Permanent address: Department of Veterinary Public Health and Research Center for Protozoan Molecular Immunology, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080, Japan

Correspondence to:

Byron Caughey, E-mail: byron_caughey@nih.gov

Received 26 February 1999; Accepted 20 April 1999; Revised 19 April 1999


In the transmissible spongiform encephalopathies, normal prion protein (PrP-sen) is converted to a protease-resistant isoform, PrP-res, by an apparent self-propagating activity of the latter. Here we describe new, more physiological cell-free systems for analyzing the initial binding and subsequent conversion reactions between PrP-sen and PrP-res. These systems allowed the use of antibodies to map the sites of interaction between PrP-sen and PrP-res. Binding of antibodies (alpha219–232) to hamster PrP-sen residues 219–232 inhibited the binding of PrP-sen to PrP-res and the subsequent generation of PK-resistant PrP. However, antibodies to several other parts of PrP-sen did not inhibit. The alpha219–232 epitope itself was not required for PrP-res binding; thus, inhibition by alpha219–232 was likely due to steric blocking of a binding site that is close to, but does not include the epitope in the folded PrP-sen structure. The selectivity of the binding reaction was tested by incubating PrP-res with cell lysates or culture supernatants. Only PrP-sen was observed to bind PrP-res. This highly selective binding to PrP-res and the localized nature of the binding site on PrP-sen support the idea that PrP-sen serves as a critical ligand and/or receptor for PrP-res in the course of PrP-res propagation and pathogenesis in vivo.

  • Keywords:

    • cell-free conversion,
    • prion protein,
    • scrapie